Cargando…

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis

BACKGROUND: Patients with coronavirus disease 2019 (COVID-19) infections often have macrovascular or microvascular thrombosis and inflammation, which are known to be associated with a poor prognosis. Heparin has been hypothesized that administration of heparin with treatment dose rather than prophyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Hyeon-Jeong, Jang, Hye Jin, Choi, Won-Il, Joh, Joonsung, Kim, Junghyun, Park, Jungeun, Choi, Miyoung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Critical Care Medicine 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10265420/ https://www.ncbi.nlm.nih.gov/pubmed/37313662 http://dx.doi.org/10.4266/acc.2022.01424

Ejemplares similares

Efficacy and safety of prone position in COVID-19 patients with respiratory failure: a systematic review and meta-analysis
por: Lee, Hyeon-Jeong, et al.
Publicado: (2022)

Early intubation and clinical outcomes in patients with severe COVID-19: a systematic review and meta-analysis
por: Lee, Hyeon-Jeong, et al.
Publicado: (2022)

Full versus prophylactic-intermediate doses of anticoagulants in COVID-19: a meta-analysis
por: Loffredo, Lorenzo, et al.
Publicado: (2022)

Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis
por: Zhang, Sirui, et al.
Publicado: (2021)

Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
por: Kuno, Toshiki, et al.
Publicado: (2021)

The Efficacy of the Prophylactic Use of Octreotide after a Pancreaticoduodenectomy
por: Moon, Hyoun Jong, et al.
Publicado: (2005)

Prophylactic Anticoagulation With Intermediate-Dose Certoparin in Vascular-Risk Pregnancies—The PACER-VARP Registry
por: Grünewald, Martin, et al.
Publicado: (2021)

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
por: Motta, Jishu Kaul, et al.
Publicado: (2020)

Safety and efficacy of prophylactic anticoagulation versus therapeutic anticoagulation in hospital‐admitted COVID‐19 patients: A systematic review and meta‐analysis of randomized controlled trials
por: Rauniyar, Robin, et al.
Publicado: (2022)

EFFICACY AND SAFETY OF THERAPEUTIC VERSUS PROPHYLACTIC ANTICOAGULATION IN PATIENTS WITH COVID-19 INFECTION: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS
por: FAIZAN, UNAIZA, et al.
Publicado: (2022)

Anticoagulation treatment and prophylactic edoxaban for cerebral sinus venous thrombosis in an adolescent with acute lymphoblastic leukemia
por: Koganesawa, Masaya, et al.
Publicado: (2021)

Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies
por: Bikdeli, Behnood, et al.
Publicado: (2020)

Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial
por: Labbe, Vincent, et al.
Publicado: (2022)

Prophylactic Anticoagulation in Nephrotic Syndrome
por: Gerstein, Jonathon, et al.
Publicado: (2023)

Prophylactic versus therapeutic dose anticoagulation effects on survival among critically ill patients with COVID-19
por: Hoogenboom, Wouter S., et al.
Publicado: (2022)

Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis
por: Liao, Zheng, et al.
Publicado: (2023)

Efficacy and safety of intensified versus standard prophylactic anticoagulation therapy in patients with Covid-19: a systematic review and meta-analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

Safety and efficacy of prophylactic tirofiban infusion for acute intracranial intraprocedural stent thrombosis
por: Sun, Lili, et al.
Publicado: (2021)

Anticoagulant Therapy in Thrombosis
por: Jorpes, J. Erik
Publicado: (1946)

Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2020)

Portomesenteric venous thrombosis in a prophylactically anticoagulated obese patient after laparoscopic sleeve gastrectomy: a case report
por: Alsannaa, Feras, et al.
Publicado: (2021)

Prophylactic anticoagulation for patients in hospital with covid-19
Publicado: (2021)

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Efficacy and Safety of Intensified Versus Standard Prophylactic Anticoagulation Therapy in Patients With Coronavirus Disease 2019: A Systematic Review and Meta-Analysis
por: Wills, Nicola K, et al.
Publicado: (2022)

Comparison of Treatment Result Between Anticoagulation Alone and Catheter-Directed Thrombolysis Plus Anticoagulation in Acute Lower Extremity Deep Vein Thrombosis
por: Choi, Young Jin, et al.
Publicado: (2019)

Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis
por: Ghandehari, Kavian, et al.
Publicado: (2013)

Is Radical Perineal Prostatectomy a Viable Therapeutic Option for Intermediate- and High-risk Prostate Cancer?
por: Lee, Hye Won, et al.
Publicado: (2015)

Thrombosis Prevention without Anticoagulation
por: Schmaier, Alvin H.
Publicado: (2014)

Thrombosis and anticoagulation in COVID-19
por: Ramos, Roberta Pulcheri, et al.
Publicado: (2020)

Bedside anti-Xa measurement for therapeutic assessment of a prophylactic anticoagulation regimen
por: Dewulf, B, et al.
Publicado: (2013)

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019)

A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome
por: Lin, Raymond, et al.
Publicado: (2019)

Efficacy and safety of metronomic chemotherapy for patients with advanced primary hepatocellular carcinoma with major portal vein tumor thrombosis
por: Woo, Hyun Young, et al.
Publicado: (2012)

Therapeutic or prophylactic anticoagulation in acute isolated distal deep vein thrombosis: protocol for a prospective, multicentre, single-blind, randomised controlled trial (TOP-IDDVT)
por: Zhou, Min, et al.
Publicado: (2022)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
por: Zakai, Neil A., et al.
Publicado: (2021)

Great saphenous vein stump: a risk factor for superficial/deep venous thrombosis and an indication for prophylactic anticoagulation? - a retrospective analysis
por: Khan, Yasir, et al.
Publicado: (2019)

COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19
por: Chambers, Isaac, et al.
Publicado: (2020)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
por: Kim, Jun Young, et al.
Publicado: (2016)

Intermediate- vs. Standard-Dose Prophylactic Anticoagulation in Patients With COVID-19 Admitted in Medical Ward: A Propensity Score-Matched Cohort Study
por: Smadja, David M., et al.
Publicado: (2021)

Safety, efficacy, and response predictors of anticoagulation for the treatment of nonmalignant portal-vein thrombosis in patients with cirrhosis: a propensity score matching analysis
por: Chung, Jung Wha, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g0nted3vfs7hvf6pi1rjbrc6ao